Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You-Cheol Hwang

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
European Journal of Endocrinology|April 25, 2014
Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucoseYou-Cheol Hwang, Hong-Yup Ahn, Sung-Woo Park, et al.
Acta Diabetologica|May 13, 2014
Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal studyYou-Cheol Hwang, Hong-Yup Ahn, Sung-Woo Park, et al.
Diabetes & Metabolism Journal|June 26, 2019
A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 InhibitorYou Cheol Hwang, Jae Hyeon Kim, Byung Wan Lee, et al.
Yonsei Medical Journal|August 10, 2017
Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in KoreansJong Dai Kim, You Cheol Hwang, Hong Yup Ahn, et al.
Diabetes/Metabolism Research and Reviews|October 31, 2009
The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjectsYou-Cheol Hwang, In-Kyung Jeong, Kyu Jeung Ahn, et al.
Diabetes & Metabolism Journal|June 9, 2016
Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in KoreansYoung Seok Song, You Cheol Hwang, Hong Yup Ahn, et al.
Medicine|June 17, 2016
Prediction of future development of cardiovascular disease with an equation to estimate apolipoprotein B: A community-based cohort studyYou-Cheol Hwang, Cheol-Young Park, Hong-Yup Ahn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 22, 2017
Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not MenYou-Cheol Hwang, Hong-Yup Ahn, Sung-Woo Park, et al.
Journal of Bone and Mineral Metabolism|May 20, 2009
The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal womenYou-Cheol Hwang, In-Kyung Jeong, Kyu Jeung Ahn, et al.
Metabolism: Clinical and Experimental|May 13, 2021
Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagyJin Yoo, In-Kyung Jeong, Kyu Jeung Ahn, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
European Journal of Endocrinology|April 25, 2014
Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucoseYou-Cheol Hwang, Hong-Yup Ahn, Sung-Woo Park, et al.
Acta Diabetologica|May 13, 2014
Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal studyYou-Cheol Hwang, Hong-Yup Ahn, Sung-Woo Park, et al.
Diabetes & Metabolism Journal|June 26, 2019
A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 InhibitorYou Cheol Hwang, Jae Hyeon Kim, Byung Wan Lee, et al.
Yonsei Medical Journal|August 10, 2017
Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in KoreansJong Dai Kim, You Cheol Hwang, Hong Yup Ahn, et al.
Diabetes/Metabolism Research and Reviews|October 31, 2009
The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjectsYou-Cheol Hwang, In-Kyung Jeong, Kyu Jeung Ahn, et al.
Diabetes & Metabolism Journal|June 9, 2016
Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in KoreansYoung Seok Song, You Cheol Hwang, Hong Yup Ahn, et al.
Medicine|June 17, 2016
Prediction of future development of cardiovascular disease with an equation to estimate apolipoprotein B: A community-based cohort studyYou-Cheol Hwang, Cheol-Young Park, Hong-Yup Ahn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 22, 2017
Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not MenYou-Cheol Hwang, Hong-Yup Ahn, Sung-Woo Park, et al.
Journal of Bone and Mineral Metabolism|May 20, 2009
The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal womenYou-Cheol Hwang, In-Kyung Jeong, Kyu Jeung Ahn, et al.
Metabolism: Clinical and Experimental|May 13, 2021
Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagyJin Yoo, In-Kyung Jeong, Kyu Jeung Ahn, et al.
Pageof 12